Ralf Kuriyel - 11 Aug 2022 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Senior VP, R&D
Signature
/s/ Kimberly Brown (Attorney in Fact)
Issuer symbol
RGEN
Transactions as of
11 Aug 2022
Net transactions value
-$1,028,575
Form type
4
Filing time
12 Aug 2022, 16:49:38 UTC
Previous filing
17 May 2022
Next filing
01 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $66,100 +2,000 +9.9% $33.05* 22,110 11 Aug 2022 Direct
transaction RGEN Common Stock Options Exercise $80,590 +1,354 +6.1% $59.52 23,464 11 Aug 2022 Direct
transaction RGEN Common Stock Options Exercise $55,621 +646 +2.8% $86.10 24,110 11 Aug 2022 Direct
transaction RGEN Common Stock Sale $204,160 -800 -3.3% $255.20 23,310 11 Aug 2022 Direct
transaction RGEN Common Stock Sale $1,026,726 -4,040 -17% $254.14 19,270 11 Aug 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +2,000 $0.000000* 0 11 Aug 2022 Common Stock 2,000 $33.05 Direct F2
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +1,354 $0.000000* 0 11 Aug 2022 Common Stock 1,354 $59.52 Direct F2
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +646 $0.000000 400 11 Aug 2022 Common Stock 646 $86.10 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 $254.14 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.10 to $254.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 This option is fully vested and exercisable.
F3 1,046 shares vest and become exercisable on 2/27/2023.